BC Cancer

Vancouver, British Columbia V5Z 4E6

2 studies enrolling now · 5 studies all time

What they study most

Advanced Melanoma, Bile Duct Cancer, Bladder Cancer, Breast Cancer, Cholangiocarcinoma, Colorectal Cancer, Esophageal Cancer, Gallbladder Cancer, HR+, HER2-, Advanced Breast Cancer, Head and Neck Cancer, Kidney Cancer, Locally Advanced Solid Tumor

Studies at this site

• Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) — Recruiting now
• A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors — Recruiting now
• Phase III Study of AK112 for NSCLC Patients — Running, not enrolling
• Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors — Stopped early
• Oral EPI-7386 in Patients with Castration-Resistant Prostate Cancer — Stopped early